ArticleFrontiers in medicine2026

Long-term outcomes of co-administration of CD19 and CD22 CAR-T cell therapy in pediatric patients with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.

Zichao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.